Myostatin Propeptide
Myostatin Propeptide
Also known as: GDF-8 Propeptide, MSTN Propeptide, Myostatin Inhibitor Propeptide
Overview
Key Facts
Primary Goal: Research and therapeutic applications of Myostatin Propeptide
Binds directly to the mature myostatin dimer, forming an inactive latent complex. Prevents myostatin from engaging ActRIIB receptors on muscle fibers.
Dosing Information
Estimated 2-4 hours (short, no Fc fusion)
50–200 mcg
Once daily (research dosing, not clinically established)
4-8 weeks (research protocols only)
Benefits
- Highly specific myostatin inhibition without broad TGF-beta pathway disruption
- Reduced off-target side effect profile compared to ActRIIB decoys
- Potential for muscle wasting therapy with fewer vascular complications
- Preserves activin and BMP signaling pathways
- May enhance muscle regeneration post-injury
Side Effects
Mechanism of Action
Binds directly to the mature myostatin dimer, forming an inactive latent complex
Prevents myostatin from engaging ActRIIB receptors on muscle fibres
Highly specific — does not significantly inhibit activin, GDF-11, or BMPs
Relieves Smad2/3-mediated transcriptional repression of muscle-specific genes
Contraindications
Do not use this peptide if any of the following apply:
- Active malignancy
- Pregnancy or breastfeeding
- Known hypersensitivity to recombinant proteins
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
The myostatin propeptide has been extensively studied in animal models. Transgenic mice overexpressing the propeptide exhibit 20-40% increases in muscle mass. Engineered variants with enhanced affinity (e.g., D76A mutant) show even greater efficacy. While no direct clinical trials of the injectable peptide exist, gene therapy approaches delivering the propeptide are in preclinical development for muscular dystrophies.
Frequently Asked Questions
Common questions about Myostatin Propeptide
UK-Specific Information
Exclusive data points and guidance for UK residents using Myostatin Propeptide
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok